Genmab | GEN - Loan Capital


Genmab reported DKK5.14B in Loan Capital for its fiscal quarter ending in December of 2025.





Loan Capital Change Date
Agios Pharmaceuticals USD 1.06M 0 Sep/2022
Almirall EUR 324.81M 61.32M Dec/2025
Amgen USD 51.89B 1.88B Mar/2026
argenx SE USD 35.57M 3.05M Jun/2025
AstraZeneca USD 25.96B 177M Mar/2026
Bayer EUR 30.68B 1.15B Mar/2026
BioMarin Pharmaceutical USD 1.43B 833.11M Mar/2026
Demant DKK 18.98B 3.71B Dec/2025
Fresenius Medical Care EUR 5.74B 895.27M Mar/2026
Genmab DKK 5.14B 5.01B Dec/2025
GlaxoSmithKline GBP 14.01B 696M Mar/2026
GN Store Nord DKK 8.1B 790M Mar/2026
GRIFOLS EUR 9.08B 612M Mar/2026
Hikma Pharmaceutical USD 1.49B 692M Dec/2025
Insmed USD 542.22M 1.25M Mar/2026
Lakefront Biotherapeutics EUR 4.85M 335K Mar/2026
Lonza CHF 3.88B 323M Dec/2025
Merck EUR 10.8B 72M Mar/2026
Novartis USD 37.45B 7.86B Mar/2026
Regeneron Pharmaceuticals USD 1.99B 719.7M Mar/2026
Roche Holding CHF 27.43B 966M Dec/2025
Sanofi EUR 13.84B 1.88B Mar/2026
UCB EUR 2.18B 634M Dec/2025